INT330874

Context Info Confidence 0.01 First Reported 2010 Last Reported 2010 Negated 0 Speculated 0 Reported most in Body Documents 1 Total Number 1 Disease Relevance 0.15 Pain Relevance 0.03

pigmentation (PLDN) cytosol (PLDN) endosome (PLDN) cytoplasm (PLDN)

PLDN (Homo sapiens)

Pain Link Frequency Relevance Heat depression 1 53.56 Pain 1 46.68 Eae 6 5.00 Neurotransmitter 2 5.00 gABA 1 5.00 withdrawal 1 5.00 anesthesia 1 5.00 Glutamate 1 5.00 Catecholamine 1 5.00

Disease Link Frequency Relevance Heat Shock 8 92.72 Depression 1 53.56 Amnesia 12 50.00 Pain 1 46.68 Toxicity 3 40.36 Decapitation 2 18.32 Disease 13 5.00 Cognitive Disorder 9 5.00 Disorder Of Lipid Metabolism 7 5.00 Dementia 2 5.00

Sentences Mentioned In

Key:

Protein

Mutation

Event

Anatomy

Negation

Speculation

Pain term

Disease term

However, PA at the dose levels 300 and 600 mg/kg showed a decrease in the TL, which is comparable to that shown by piracetam (P < 0.01) [Table 1].

Negative_regulation (decrease) of PA

1) Confidence 0.01 Published 2010 Journal Indian Journal of Pharmacology Section Body Doc Link PMC2937319 Disease Relevance 0.15 Pain Relevance 0.03

General Comments

This test has worked.